Centre bans 16 drug combinations over safety concerns and lack of medical justification
PTC Web Desk: The Union Health Ministry has banned the manufacture, sale and distribution of 16 fixed-dose combination (FDC) medicines across the country, saying the products lack adequate medical justification and may pose risks to patients.
The decision was announced through official notifications issued by the Department of Health and Family Welfare. The ban comes after a detailed regulatory review conducted over several years under the provisions of the Drugs and Cosmetics Act, 1940.
According to health authorities, expert committees examined the scientific evidence available for these drug combinations and found that many of them offered no proven therapeutic advantage. In several cases, the combinations were considered medically irrational and not supported by standard treatment guidelines.
Among the products affected are combinations involving antibiotics such as amoxicillin, cefuroxime and cefadroxyl paired with other ingredients that experts said do not contribute meaningfully to treatment outcomes. Certain digestive and pain-relief combinations, diabetes medicines and a number of aloe vera-based topical products have also been prohibited.
Experts reviewing the medicines noted that some combinations included ingredients with overlapping functions, while others lacked sufficient clinical data to prove their effectiveness or safety. In the case of a diabetes medication containing chromium picolinate, the review found that the ingredient is not recommended in widely accepted treatment guidelines.
The decision follows recommendations made by expert panels and the Drugs Technical Advisory Board (DTAB), which reviewed scientific evidence and sought feedback from manufacturers and stakeholders before reaching a final conclusion.
After examining the findings, the government determined that continued availability of these products was not in the interest of public health. As a result, companies can no longer legally manufacture, market or distribute the banned drug combinations for human use in India.
Health officials said the move is aimed at ensuring that only scientifically supported and clinically appropriate medicines remain available to patients across the country.
Acetyl Salicylic Acid Ethoheptazine; Aloe Vera Jojoba Oil Wheat Germ Oil Tea Tree Oil; Amoxicillin Serratiopeptidase Lactobacillus Sporogenes; Dicyclomine Paracetamol Clidinium Bromide Chlordiazepoxide; Amoxicillin Serratiopeptidase; Aloe Extract Allantoin Alpha Tocopherol Acetate D-Penthenol Vitamin A; Aloe Extract Vitamin E Dimethicone Glycerine; Aloe Vera Jojoba Oil Vitamin E; Aloe Vera Orange Oil; Aloe Vera Vitamin E Herbal; Dicyclomine Paracetamol Clidinium Bromide; Paracetamol Lignocaine; Gliclazide Chromium Picolinate; Amoxicillin Cloxacillin Lactic Acid Bacillus Serratiopeptidase; Cefadroxyl Probenecid; and Cefuroxime Serratiopeptidase.
- With inputs from agencies
